Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward C Keystone

Showing results (41-50 of 159) with videos related to

Pageof 16
Sort By:
The Journal of Rheumatology|December 3, 2013
Clinical, functional, and radiographic implications of time to treatment response in patients with early rheumatoid arthritis: a posthoc analysis of the PREMIER studyEdward C Keystone, Boulos Haraoui, Benoît Guérette, et al.
The Journal of Rheumatology|November 3, 2014
Is structural damage evaluation by traditional radiographs still relevant in rheumatoid arthritis clinical trials?Boulos Haraoui, Jacob Karsh, Janet E Pope, et al.
The Journal of Rheumatology|January 17, 2014
Continued benefit of tocilizumab plus disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis and inadequate clinical responses by week 8 of treatmentEdward C Keystone, Andrew Anisfeld, Sarika Ogale, et al.
RMD Open|June 30, 2018
Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritisEdward C Keystone, Ferdinand C Breedveld, Hartmut Kupper, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 11, 2013
Turkish experience in rheumatoid arthritis patients with clinical apparent amyloid depositionOmer Nuri Pamuk, Salim Donmez, Gulsum Emel Pamuk, et al.
Current Medical Research and Opinion|March 26, 2009
Effectiveness and safety of etanercept in subjects with RA who have failed infliximab therapy: 16-week, open-label, observational studyClifton O Bingham, Akgun Ince, Boulos Haraoui, et al.
The Journal of Rheumatology|July 5, 2011
Efficacy and safety of CH-1504, a metabolically stable antifolate, in patients with active rheumatoid arthritis: results of a phase II multicenter randomized studyEdward C Keystone, Valery S Shirinsky, Lee S Simon, et al.
Clinical and Experimental Rheumatology|April 30, 2013
Achieving remission in clinical practice: lessons from clinical trial dataVivian P Bykerk, Edward C Keystone, Bindee Kuriya, et al.
Annals of the Rheumatic Diseases|April 22, 2021
Primary and secondary non-response: in need of operational definitions in observational studiesEnriqueta Vallejo-Yagüe, Edward C Keystone, Sreemanjari Kandhasamy, et al.
Arthritis Care & Research|July 31, 2014
Analysis of integrated radiographic data from two long-term, open-label extension studies of adalimumab for the treatment of rheumatoid arthritisRobert Landewé, Mikkel Østergaard, Edward C Keystone, et al.
Pageof 16

Showing results (41-50 of 159) with videos related to

Sort By:
Pageof 16
The Journal of Rheumatology|December 3, 2013
Clinical, functional, and radiographic implications of time to treatment response in patients with early rheumatoid arthritis: a posthoc analysis of the PREMIER studyEdward C Keystone, Boulos Haraoui, Benoît Guérette, et al.
The Journal of Rheumatology|November 3, 2014
Is structural damage evaluation by traditional radiographs still relevant in rheumatoid arthritis clinical trials?Boulos Haraoui, Jacob Karsh, Janet E Pope, et al.
The Journal of Rheumatology|January 17, 2014
Continued benefit of tocilizumab plus disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis and inadequate clinical responses by week 8 of treatmentEdward C Keystone, Andrew Anisfeld, Sarika Ogale, et al.
RMD Open|June 30, 2018
Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritisEdward C Keystone, Ferdinand C Breedveld, Hartmut Kupper, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 11, 2013
Turkish experience in rheumatoid arthritis patients with clinical apparent amyloid depositionOmer Nuri Pamuk, Salim Donmez, Gulsum Emel Pamuk, et al.
Current Medical Research and Opinion|March 26, 2009
Effectiveness and safety of etanercept in subjects with RA who have failed infliximab therapy: 16-week, open-label, observational studyClifton O Bingham, Akgun Ince, Boulos Haraoui, et al.
The Journal of Rheumatology|July 5, 2011
Efficacy and safety of CH-1504, a metabolically stable antifolate, in patients with active rheumatoid arthritis: results of a phase II multicenter randomized studyEdward C Keystone, Valery S Shirinsky, Lee S Simon, et al.
Clinical and Experimental Rheumatology|April 30, 2013
Achieving remission in clinical practice: lessons from clinical trial dataVivian P Bykerk, Edward C Keystone, Bindee Kuriya, et al.
Annals of the Rheumatic Diseases|April 22, 2021
Primary and secondary non-response: in need of operational definitions in observational studiesEnriqueta Vallejo-Yagüe, Edward C Keystone, Sreemanjari Kandhasamy, et al.
Arthritis Care & Research|July 31, 2014
Analysis of integrated radiographic data from two long-term, open-label extension studies of adalimumab for the treatment of rheumatoid arthritisRobert Landewé, Mikkel Østergaard, Edward C Keystone, et al.
Pageof 16